Neurodevelopment in School-aged Children After Intrauterine Exposure to Antipsychotics

Overview

Journal Acta Psychiatr Scand

Specialty Psychiatry

Date 2022 Nov 5

PMID 36333825

Authors

Lisanne Schrijver

Thalia K Robakis

Astrid M Kamperman

Hilmar Bijma

Adriaan Honig

Inge L van Kamp

Witte J G Hoogendijk

Veerle Bergink

Eline M P Poels

Affiliations

Soon will be listed here.

Abstract

Objective: Antipsychotics are increasingly prescribed in pregnancy, yet little is known about potential long-term developmental effects on children. In this study, we investigated the effect of prenatal antipsychotic exposure on neurodevelopmental functioning in school-aged children.

Methods: We performed a cross-sectional neurodevelopmental assessment of 91 children aged 6-14 years whose mothers had severe mental illness and were either exposed or unexposed to antipsychotic medication during pregnancy. Neurodevelopmental outcomes were assessed using validated neurodevelopmental assessment instruments to examine the child's IQ and global cognitive functioning, and the presence of any psychiatric disorders and/or learning problems in the child was assessed by parental report.

Results: No statistically significant associations were found between antipsychotic exposure during pregnancy and either adverse neurodevelopmental outcomes (IQ, neuropsychological function), likelihood of psychiatric diagnosis, or learning problems based on parental report. Analyses were likely limited in power to detect subtler differences in neurodevelopmental functioning because of small sample size and heterogeneity of the sample.

Conclusions: In this exploratory cohort study, intrauterine exposure to antipsychotics was not associated with any adverse effect on IQ or neurodevelopmental functioning in a cohort of school-aged children (6-14 years).

Citing Articles

Prenatal exposure to psychotropics and analgesics on cognitive, linguistic and educational outcomes - a scoping review with focus on validity and reliability of outcome measures.

Reddy A, Fawad F, Leite M, Olstad E, Gervin K, Kanduri C BMC Pregnancy Childbirth. 2025; 25(1):234.

PMID: 40033241 PMC: 11877934. DOI: 10.1186/s12884-025-07235-6.

Is Antipsychotic Drug Use During Pregnancy Associated with Increased Malformation Rates and Worsening of Maternal and Infant Outcomes? A Systematic Review.

Sani G, Callovini T, Ferrara O, Segatori D, Margoni S, Simonetti A Curr Neuropharmacol. 2024; 22(14):2402-2421.

PMID: 38766824 PMC: 11451318. DOI: 10.2174/1570159X22666240516151449.

Antipsychotic use during pregnancy and risk of specific neurodevelopmental disorders and learning difficulties in children: a multinational cohort study.

Bruno C, Cesta C, Hjellvik V, Ulrichsen S, Bjork M, Esen B EClinicalMedicine. 2024; 70:102531.

PMID: 38685931 PMC: 11056394. DOI: 10.1016/j.eclinm.2024.102531.

Neurodevelopment in school-aged children after intrauterine exposure to antipsychotics.

Schrijver L, Robakis T, Kamperman A, Bijma H, Honig A, van Kamp I Acta Psychiatr Scand. 2022; 147(1):43-53.

PMID: 36333825 PMC: 10099404. DOI: 10.1111/acps.13517.

References

Poels E, Schrijver L, White T, Roza S, Zarchev M, Bijma H . The effect of prenatal lithium exposure on the neuropsychological development of the child. Bipolar Disord. 2021; 24(3):310-319. PMC: 9293321. DOI: 10.1111/bdi.13133. View

Burgerhout K, Kamperman A, Roza S, Lambregtse-van den Berg M, Koorengevel K, Hoogendijk W . Functional Recovery After Postpartum Psychosis: A Prospective Longitudinal Study. J Clin Psychiatry. 2016; 78(1):122-128. DOI: 10.4088/JCP.15m10204. View

Moody C, Robinson S, Spear L, Smotherman W . Fetal behavior and the dopamine system: activity effects of D1 and D2 receptor manipulations. Pharmacol Biochem Behav. 1993; 44(4):843-50. DOI: 10.1016/0091-3057(93)90015-l. View

Cipriani A, Barbui C, Salanti G, Rendell J, Brown R, Stockton S . Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet. 2011; 378(9799):1306-15. DOI: 10.1016/S0140-6736(11)60873-8. View

Schrijver L, Robakis T, Kamperman A, Bijma H, Honig A, van Kamp I . Neurodevelopment in school-aged children after intrauterine exposure to antipsychotics. Acta Psychiatr Scand. 2022; 147(1):43-53. PMC: 10099404. DOI: 10.1111/acps.13517. View

Poels E, Sterrenburg K, Wierdsma A, Wesseloo R, Beerthuizen A, van Dijke L . Lithium exposure during pregnancy increases fetal growth. J Psychopharmacol. 2020; 35(2):178-183. PMC: 7859661. DOI: 10.1177/0269881120940914. View

Hastie R, Tong S, Hiscock R, Lindquist A, Lindstrom L, Wikstrom A . Maternal lithium use and the risk of adverse pregnancy and neonatal outcomes: a Swedish population-based cohort study. BMC Med. 2021; 19(1):291. PMC: 8641220. DOI: 10.1186/s12916-021-02170-7. View

Ghimire U, Papabathini S, Kawuki J, Obore N, Musa T . Depression during pregnancy and the risk of low birth weight, preterm birth and intrauterine growth restriction- an updated meta-analysis. Early Hum Dev. 2020; 152:105243. DOI: 10.1016/j.earlhumdev.2020.105243. View

van Zijl M, Koullali B, Oudijk M, Ravelli A, Mol B, Pajkrt E . Trends in preterm birth in singleton and multiple gestations in the Netherlands 2008-2015: A population-based study. Eur J Obstet Gynecol Reprod Biol. 2020; 247:111-115. DOI: 10.1016/j.ejogrb.2020.02.021. View

10.

Poels E, Schrijver L, Kamperman A, Hillegers M, Hoogendijk W, Kushner S . Long-term neurodevelopmental consequences of intrauterine exposure to lithium and antipsychotics: a systematic review and meta-analysis. Eur Child Adolesc Psychiatry. 2018; 27(9):1209-1230. PMC: 6133089. DOI: 10.1007/s00787-018-1177-1. View

11.

Wolgast E, Lilliecreutz C, Sydsjo G, Bladh M, Josefsson A . The impact of major depressive disorder and antidepressant medication before and during pregnancy on obstetric and neonatal outcomes: A nationwide population-based study. Eur J Obstet Gynecol Reprod Biol. 2020; 257:42-50. DOI: 10.1016/j.ejogrb.2020.11.062. View

12.

Adane A, Bailey H, Morgan V, Galbally M, Farrant B, Marriott R . The impact of maternal prenatal mental health disorders on stillbirth and infant mortality: a systematic review and meta-analysis. Arch Womens Ment Health. 2021; 24(4):543-555. DOI: 10.1007/s00737-020-01099-9. View

13.

Boden R, Lundgren M, Brandt L, Reutfors J, Kieler H . Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects. Arch Gen Psychiatry. 2012; 69(7):715-21. DOI: 10.1001/archgenpsychiatry.2011.1870. View

14.

Toh S, Li Q, Cheetham T, Cooper W, Davis R, Dublin S . Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries. Arch Womens Ment Health. 2013; 16(2):149-57. PMC: 3715880. DOI: 10.1007/s00737-013-0330-6. View

15.

Newport D, Calamaras M, Devane C, Donovan J, Beach A, Winn S . Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry. 2007; 164(8):1214-20. DOI: 10.1176/appi.ajp.2007.06111886. View

16.

Grace T, Bulsara M, Robinson M, Hands B . The Impact of Maternal Gestational Stress on Motor Development in Late Childhood and Adolescence: A Longitudinal Study. Child Dev. 2015; 87(1):211-20. DOI: 10.1111/cdev.12449. View

17.

Slone D, Siskind V, Heinonen O, Monson R, Kaufman D, Shapiro S . Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol. 1977; 128(5):486-8. DOI: 10.1016/0002-9378(77)90029-1. View

18.

Halfdanarson O, Cohen J, Karlstad O, Cesta C, Bjork M, Haberg S . Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study. Evid Based Ment Health. 2021; 25(2):54-62. PMC: 9046752. DOI: 10.1136/ebmental-2021-300311. View

19.

Petersen I, McCrea R, Osborn D, Evans S, Pinfold V, Cowen P . Discontinuation of antipsychotic medication in pregnancy: a cohort study. Schizophr Res. 2014; 159(1):218-25. DOI: 10.1016/j.schres.2014.07.034. View

20.

Momen N, Robakis T, Liu X, Reichenberg A, Bergink V, Munk-Olsen T . In utero exposure to antipsychotic medication and psychiatric outcomes in the offspring. Neuropsychopharmacology. 2021; 47(3):759-766. PMC: 8782838. DOI: 10.1038/s41386-021-01223-y. View